Smith Anglin Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,366
| Closed | -$1M | – | 140 |
|
|
2021
Q4 | $1M | Sell |
16,366
-1,439
| -8% | -$88.1K | 0.17% | 56 |
|
|
2021
Q3 | $1.33M | Sell |
17,805
-2,444
| -12% | -$183K | 0.26% | 50 |
|
|
2021
Q2 | $1.87M | Sell |
20,249
-337
| -2% | -$31.2K | 0.36% | 40 |
|
|
2021
Q1 | $1.83M | Buy |
20,586
+3,213
| +18% | +$285K | 0.39% | 40 |
|
|
2020
Q4 | $1.62M | Buy |
+17,373
| New | +$1.62M | 0.29% | 42 |
|